| ¿µ¹® | immunity | ÇÑ±Û | ¸é¿ª |
|---|---|---|---|
| ¼³¸í | ¸ö¼Ó¿¡ µé¾î¿Â º´¿ø ¹Ì»ý¹°¿¡ ´ëÇ×ÇÏ´Â Ç×ü¸¦ »ý»êÇÏ¿© µ¶¼Ò¸¦ ÁßÈÇϰųª º´¿ø ¹Ì»ý¹°À» Á׿©¼ ´ÙÀ½¿¡´Â ±× º´¿¡ °É¸®Áö ¾Êµµ·Ï µÈ »óÅÂ. ¶Ç´Â ±×·± ÀÛ¿ë. º´¿ø¼º¹Ì»ý¹° ¹× ÀÌÁ¾´Ü¹éÁú, ´Ù´çü-ÁöÁú µîÀÇ Ä§ÀÔ, ¶Ç´Â ÀÌÇü ¼öÇ÷, Á¶Á÷ ÀÌ½Ä µî, Æø³Ð°Ô ÀÚ±â ÀÌ¿ÜÀÇ À̹°ÀÌ Ä§ÀÔÇÏ¿´À» ¶§ Àڱ⸦ ¹æÀ§ÇÏ´Â »ýü¹ÝÀÀÀ» ¸»ÇÑ´Ù. ¿ø·¡ ÀÏ´Ü °¨¿°Áõ¿¡ °É¸®°í ȸº¹µÇ¸é, Æò»ý ±× º´¿¡ °É¸®Áö ¾Ê´Â ¡®Àç¹ßÇÏÁö ¾Ê´Â Çö»ó¡¯À» ÀǹÌÇÏ¿´Áö¸¸, ÇöÀç´Â »ç¶÷À̳ª µ¿¹°ÀÌ, À̹°ÀÇ Ä§ÀÔ¿¡ ´ëÇØ, °¢°¢ ´ëÀÀÇÑ Ç×ü¸¦ »ý»êÇÏ¿© ÀúÇ×¼ºÀ» ¾ò´Â »óŸ¦ ¸»ÇÑ´Ù. ¸é¿ª¿¡´Â ž¸é¼ºÎÅÍ °®°í ÀÖ´Â ÀÚ¿¬¸é¿ª°ú, »ýÈÄ Ç׿ø°ú Á¢ÇÏ°Ô µÊ¿¡ µû¶ó ¾ò¾îÁö´Â ȹµæ¸é¿ªÀÌ ÀÖÀ¸¸ç, ȹµæ¸é¿ª¿¡´Â ´Éµ¿¸é¿ª°ú ¼öµ¿¸é¿ªÀÌ ÀÖ´Ù. ´Éµ¿¸é¿ª¿¡´Â Áúº´ ȸº¹ ÈÄ¿¡ ¾ò¾îÁö´Â º´ÈÄ ¸é¿ª°ú ¹é½Åµî¿¡ ÀÇÇÑ ¿¹¹æÁ¢Á¾ °á°ú·Î ¾ò¾îÁö´Â ÀΰøÀû ¹æ¹ýÀÌ ÀÖ´Ù. ¼öµ¿¸é¿ªÀº ¸é¿ªÇ×ü¸¦ °®´Â Ç÷ûÀ» ÁÖ»çÇØ¼ ¾òÀ» ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | cell-mediated immunity | ÇÑ±Û | ¼¼Æ÷¸Å°³¸é¿ª |
|---|---|---|---|
| ¼³¸í | ¸é¿ªÀ̶õ ½Åü¸¦ ¿ÜºÎÀÇ ¹°Áú·ÎºÎÅÍ º¸È£ÇÏ´Â ÇàÀ§¸¦ ¸»ÇÑ´Ù. ¿©±â¿¡´Â ƯÀÌÀû ¸é¿ª°ú ºñƯÀÌÀû ¸é¿ªÀÇ µÎ °¡Áö°¡ ÀÖ´Ù. ºñƯÀÌÀû ¸é¿ªÀ̶óÇÔÀº ƯÁ¤ÇÑ ¹°Áú¿¡ °ü°èÇÏ´Â ¸é¿ªÀÌ ¾Æ´Ï¶ó ƯÁ¤ ´ë»óÀÌ ¾øÀÌ ¸ðµç ¿ÜºÎ ¹°Ã¼¿¡ ÀÛ¿ëÇÒ ¼ö ÀÖ´Â ¸é¿ªÀ» ¸»ÇÑ´Ù. ¿©±â¿¡´Â ¼Òº¯ÀÇ È帧, ´«¹°ÀÇ È帧, ÇǺÎÀÇ ºñÅõ°ú¼º µîÀÇ ±â°èÀûÀÎ °Íµµ Æ÷ÇԵǰí ÇǼӿ¡ µ¹¾Æ´Ù´Ï´Â ¼¼Æ÷ Áß¿¡¼ ºñƯÀÌÀûÀ¸·Î ¿ÜºÎÀÇ ¹°ÁúÀ» Æ÷½ÄÇÏ´Â ¼¼Æ÷µé(¿¹¸¦ µé¸é Å«Æ÷½Ä¼¼Æ÷(macrophage)ÀÇ È°µ¿µµ Æ÷ÇÔÀÌ µÈ´Ù. ¼¼Æ÷¸Å°³¸é¿ªÀ̶õ ƯÀÌÇÑ ¹°ÁúÀ» °¨ÁöÇÒ ¼ö ÀÖ´Â ¼¼Æ÷¸¦ »ý¼ºÇÏ°Ô ÇÏ¿© ±×°ÍÀ¸·Î ÇÏ¿©±Ý ±× ¹°ÁúÀ» Æ÷½ÄÇÏ°Ô ÇÏ´Â °ÍÀ» ¸»ÇÑ´Ù. |
||
| CMI | 1) Cornell Medical Index 2) Cell-Mediated Immunity |
|---|---|
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
| CIDS | cellular immunity deficiency syndrome; circular intensity differential scattering; continuous insuli... |
| CMI | carbohydrate metabolism index; care management integration; case mix index; cell-mediated immunity; ... |
| HI | half-scan with interpolation; head injury; health insurance; hearing impaired; heart infusion; hemag... |
| CMI | Cell mediated immunity |
|---|
| lysogenic | 1. Causing or having the power to cause lysis, as the action of certain antibodies and chemical substances. 2. Pertaining to bacteria in the state of lysogeny. (05 Mar 2000) |
|---|---|
| lysogenic bacteria | <microbiology> A bacterium which contains in its genome the DNA of a virus which is lying dormant, passively letting itself be replicated by the bacterium whenever the bacterium replicates its own genome (a lysogenic virus), but able to reactivate and destroy the bacterium at a time of the virus's choosing (becomes a lytic virus). (15 Oct 1997) |
| lysogenic bacterium | A bacterium in the symbiotic condition in which its genome includes the genome (probacteriophage) of a temperate bacteriophage; in occasional instances the probacteriophage dissociates from the bacterial genome, develops into vegetative bacteriophage, and then matures, causing lysis of the respective host bacterium and release into the culture medium of infective temperate bacteriophage, formerly, a pseudolysogenic bacterial strain, i.e., a "carrier" strain of bacteriophage of low infectivity. (05 Mar 2000) |
| lysogenic conversion | <virology> The ability of some phages to survive in a bacterium as a result of the integration of their DNA into the host chromosome. The integrated DNA is termed a prophage. A regulator gene produces a repressor protein that suppresses the lytic activity of the phage, but various environmental factors, such as ultraviolet irradiation may prevent synthesis of the repressor, leading to normal phage development and lysis of the bacterium. The best example of this is bacteriophage lambda. (18 Nov 1997) |
| lysogenic induction | Induction that occurs when prophage is transferred to a nonlysogenic bacterium by conjugation or by transduction. (05 Mar 2000) |
| lysogenic infection | An infective process characterised by the incorporation of the DNA of the infecting phage into the host cell chromosome. Once incorporated, the phage DNA replicates along with the host DNA. The incorporated phage DNA is relatively inactive, thus permitting the host cell to continue fairly normal life processes. (14 Nov 1997) |
| lysogenic pathway | <virology> The method by which a virus becomes a dormant, passive part of its host bacterium's genome (a lysogenic virus), choosing to insert its DNA into the host's and postponing completion of its lytic cycle, at which time it destroys the host and spreads its progeny to infect other bacterial cells (enters the lytic pathway). (09 Oct 1997) |
| lysogenic strain | A strain of bacterium that is infected with a temporate bacteriophage. See: lysogeny. (05 Mar 2000) |
| lysogenic virus | <virology> A virus which has the capability to insert its DNA into the genome of the host bacterium for long-term dormancy, so that the bacterium replicates the viral DNA along with its own and passes it to its offspring. The virus is able to choose when it wants to reactivate and finish its lytic cycle, at which time it destroys the host and spreads its progeny to infect other bacterial cells. (09 Oct 1997) |
| acquired immunity | <immunology> A form of cellular defense which identifies certain foreign substances (antigens) as harmful to the body. For this reason, the body can acquire resistance to a particular foreign agent. These foreign agents are then attacked by sensitised T lymphocytes (cellular immunity). White blood cells, plasma cells, B lymphocytes and other specialised immune system cells act in concert with T lymphocytes to produce antibodies (humoral immunity) that attach to the antigen directing T-cells to attack. Antibodies also stimulate the release of special chemical mediators in the blood (for example complement, interferon) that further enhance antigen destruction. (13 Nov 1997) |
| active immunity | <immunology> An organisms resistance to disease or infection, developed because the organisms immune system has produced antibodies after an infection or innoculation. (06 May 1997) |
| adoptive immunity | <immunology> Immunity to disease or infection conferred on a previously non-immune individual by transferring lymphocytes from a previously immune individual to the non-immune individual. (15 Jan 1998) |
| allograft immunity | <immunology> The recipient's immune system rejects tissue grafted from a genetically dissimilar donor (of the same species) and stages an immune attack against it. (09 Oct 1997) |
| antiviral immunity | Immunity resulting from virus infection, either naturally acquired or produced by intentional vaccination; compared to some bacterial immunity's, it is of relatively long duration, but this may be the result of infection-immunity rather than being peculiar to virus infection per se, since it occurs also in bacterial immunity after infections such as typhoid fever. (05 Mar 2000) |
| artificial active immunity | See: acquired immunity. (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|